© 2025 MergersCorp M&A International.
is a global brand operating through a number of professional firms and constituent entities located throughout the world to provide M&A Advisory and other client related professional services. The Member Firms are constituted and regulated in accordance with relevant local regulatory and legal requirements. For more details on the nature of our affiliation, please visit us on our website https://dev.cherrycoding.com/mergerscorp/disclaimer. MergersCorp M&A International is not a registered broker-dealer under the U.S. securities laws.
This website does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation of any security or any other product or service by MergersUS Inc. or any other third party regardless of whether such security, product or service is referenced in this website. Furthermore, nothing in this website is intended to provide tax, legal, or investment advice and nothing in this website should be construed as a recommendation to buy, sell, or hold any investment or security or to engage in any investment strategy or transaction.MergersCorp M&A International franchising program is not offered to individuals or entities located in the United States
The franchising program is offered by MergersUK Limited a UK Company with registered office at 71-75 Shelton Street, Covent Garden, London, WC2H 9JQ, United Kingdom
一个经过市场验证的健康和保健投资回报率软件平台可通过资产交易进行收购或兼并。 这一全球部署的成果管理和投资回报率分析及战略规划解决方案被雇主(包括跨国公司和本地公司)、制药公司、福利顾问、医疗保健支付方和健康服务提供商用于衡量身体、行为和职业健康领域干预计划的成果和投资回报率(ROI)。
该资产拥有专有软件知识产权、全球分销关系以及针对各国生产力损失模型的精选数据库,非常适合整合到现有的数字医疗、EAP、福利咨询、HEOR/制药或分析业务中。
未来发展计划:
© 2025 MergersCorp M&A International is a global brand operating through a number of professional firms and constituent entities (“Members”) located throughout the world to provide Investment Banking, Corporate Finance, and Advisory Services and other client-related professional services. The Member Firms (“Members”) are constituted and regulated in accordance with relevant local regulatory and legal requirements. For more details on the nature of our affiliation, please visit our Disclaimer: https://mergerscorp.com/disclaimer. MergersCorp M&A International's franchising program is not offered to individuals or entities located in the United States.
The franchising program is offered by MergersUK Limited, a UK Company with its registered office at 71-75 Shelton Street, Covent Garden, London, WC2H 9JQ, United Kingdom.
MergersCorp M&A International provides strategic business advisory services, including preparing companies for growth and capital access. Through partnerships with licensed investment bankers, clients can access tailored capital-raising solutions.
U.S. Investment Banking Securities transactions are exclusively conducted by Spektrum Capital Advisors LLC, a Registered Representative of, and Securities Products offered through, BA Securities, LLC, a FINRA-registered broker-dealer. Check the background of investment professionals associated with this site on Broker Check.
This website is operated by MergersUS Inc a US Corporation with registered office at





描述
一个经过市场验证的健康和保健投资回报率软件平台可通过资产交易进行收购或兼并。 这一全球部署的成果管理和投资回报率分析及战略规划解决方案被雇主(包括跨国公司和本地公司)、制药公司、福利顾问、医疗保健支付方和健康服务提供商用于衡量身体、行为和职业健康领域干预计划的成果和投资回报率(ROI)。
该资产拥有专有软件知识产权、全球分销关系以及针对各国生产力损失模型的精选数据库,非常适合整合到现有的数字医疗、EAP、福利咨询、HEOR/制药或分析业务中。
资产出售包括
平台优势
服务
促销活动
未来发展计划:
Basic Details
Target Price:
EUR 1,350,000
Business ID:
L#20250908
Country
美国
详情
Similar Businesses
Published on 27 4 月, 2025 在 3:04 下午. 更新 27 4 月, 2025 在 3:04 下午
快速增长的 SaaS 和食品配送服务
$1,700,000
软件和 SAAS
处理业务通信的国际 IT SaaS 公司
$28,812,579
软件和 SAAS
软件开发公司
待定
软件和 SAAS
用于社交聆听和数据分析的 SAAS 自然语言处理业务
€1,000,000
软件和 SAAS
快速增长的食品配送服务和 SaaS
$1,700,000
软件和 SAAS
高增长数字转型公司
$26,000,000
软件和 SAAS
PREVIOUS PROPERTY
塞浦路斯投资公司(CIF)
NEXT PROPERTY
横跨 CX、EX、UX 和 DX 的统一 MX 解决方案的领导者